Abstract
Objective
The role of anxiety in the use of urgent care in people with long term conditions is not fully understood. A systematic review was conducted with meta-analysis to examine the relationship between anxiety and future use of urgent healthcare among individuals with one of four long term conditions: diabetes; coronary heart disease, chronic obstructive pulmonary disease and asthma.
Methods
Electronic searches of MEDLINE, EMBASE, PSYCINFO, CINAHL, the British Nursing Library and the Cochrane Library were conducted These searches were supplemented by hand-searching bibliographies, citation tracing eligible studies and asking experts within the field about relevant studies. Studies were eligible for inclusion if they: a) used a standardised measure of anxiety, b) used prospective cohort design, c) included adult patients diagnosed with coronary heart disease (CHD), asthma, diabetes or chronic obstructive pulmonary disease (COPD), d) assessed urgent healthcare use prospectively. Data regarding participants, methodology, and association between anxiety and urgent care use was extracted from studies eligible for inclusion. Odds ratios were calculated for each study and pooled using random effects models.
Results
8 independent studies were identified for inclusion in the meta-analysis, with a total of 28,823 individual patients. Pooled effects indicate that anxiety is not associated with an increase in the use of urgent care (OR = 1.078, p = 0.476), regardless of the type of service, or type of medical condition.
Conclusions
Anxiety is not associated with increased use of urgent care. This finding is in contrast to similar studies which have investigated the role of depression as a risk factor for use of urgent care.
Keywords: Anxiety, Urgent care, Long term conditions, Diabetes' asthma, Chronic obstructive pulmonary disease, Coronary heart disease
Highlights
-
•
Anxiety was not significantly associated with increased use of urgent healthcare (UC).
-
•
Effect of anxiety was not statistically significant across different types of UC.
-
•
Effect of anxiety was not statistically significant in different long term conditions.
Introduction
Long term conditions (LTCs) are common and are associated with high healthcare costs. Globally, 50–80% of all healthcare spending is related to LTCs [1] with approximately 78% of the entire healthcare budget of the United States of America spent on providing healthcare for people with LTCs [2] and 69% of the healthcare budget in England allocated to the care of individuals with LTCs [3]. A disproportionate amount of healthcare costs are spent on urgent healthcare, some of which may be avoidable [4], [5], [6]. In the UK, there has been an increase in the use of urgent care over the last decade with an ever increasing number of patients presenting to Emergency Departments [7], [8], [9]. The reason for this is likely to be multi-factorial and to include factors related to organisational issues around the delivery of healthcare, disease severity, an ageing population with complex disease co-morbidity, and a variety of other, as of yet, unidentified factors.
Depression and anxiety and common co morbidities of LTCs and are associated with negative health outcomes such as: significant role impairment [10], [11], increased physical morbidity [12], [13] increased mortality [14], [15], poorer quality of life [16], [17], increased re-admission rates following hospital discharge [18], [19], [20], increased healthcare costs [21], [22], [23], and loss of work days [24], [25], [26]. However, much research has focused on the relationship between depression and LTCs, and less is known about the effect of co-morbid anxiety disorders. Anxiety disorders occur in approximately 18.1%–33% of the general population at any period of time [27], [28] and the lifetime prevalence is approximately 28.8% [27]. The prevalence of anxiety symptoms in LTCs is much higher than that in the general population, reaching up to 69% for some conditions [29], [30]. Anxiety disorders are associated with significant functional impairment and poor disease control in the context of certain LTCs [31], [32].
In a recent systematic review, it was shown that depression is associated with an increase in the use of urgent care in people with LTCs by approximately 50% [23]. However, the impact of anxiety on urgent care use remains unclear. Therefore, we have conducted a systematic review of the literature with meta-analysis to clarify the extent to which anxiety predicts urgent care use in people with LTCs.
Method
Four non-communicable, exemplar LTCs were chosen for the purposes of the review: chronic obstructive pulmonary disease (COPD), coronary heart disease (CHD), asthma and diabetes. These four conditions contribute as the leading non-communicable causes of death worldwide, when excluding cancer [33].
The methods and results for this review are reported in line with the PRISMA Guidlelines [34].
Eligibility criteria
The study team included papers which met the following criteria;
-
1.
Included adults (over 18 years of age) with one or more of the following LTCs: diabetes (type 1, type 2 or unspecified), asthma (acute or chronic), COPD (acute or chronic), or CHD (myocardial infarction, stable or unstable angina), presenting results independently to any further LTMCs not included in the review criteria.
-
2.
Prospective cohort study design.
-
3.
Included a standardised measure of anxiety at baseline.
-
4.
Assessed urgent healthcare use prospectively.
Urgent care was defined as any of the following: unscheduled visits to GP, consultant, or specialist nurse; visits to accident and emergency, walk in clinics, or other urgent hospitalizations; as well as costing data for these events.
In order to maximise the number of studies included within the review we did not exclude studies due to the way in which anxiety was assessed provided that patients were assessed using a valid, standardised anxiety measure. We also included all studies which used prospective, standardised measures of urgent care.
Studies were included within the review regardless of date or language of publication, sample size or length of follow up period. Papers presented in non-English languages were translated prior to screening. However, studies only available in conference abstract form, or as of the time of searching, unpublished papers, were not included in the review. This decision was made so as to ensure papers included were of high methodological quality, and typical of other published papers included. See Appendix A for full exclusion and inclusion criteria.
Study selection
Team members with experience of conducting systematic reviews conducted in-team electronic search strategies in MEDLINE, EMBASE, PSYCHINFO, CINAHL, The British Nursing Index (using OVID search interface) and the Cochrane Library, retrieving papers from the inception of each of these databases up until the search date. Search strategies included terms of reference relevant to CHD, COPD, asthma and/or diabetes, as well as terms relevant to healthcare use, and were limited to prospective studies (see Appendix A for detailed accounts of search strategies used). As there was no medical subject heading (MeSH) terms relevant to the use of unscheduled care, electronic searches were conducted for studies relevant to all healthcare utilisation. The subset of studies that collected data on unscheduled care was identified by the research team hand-searching studies of all healthcare utilisation.
Electronic searches were first conducted in 2008 and updated periodically until 2013. Electronic searches were supplemented by hand searches of papers meeting inclusion criteria, and relevant papers were citation searched using the Social Science Citation Index.
Titles and abstracts of papers were screened by one of five researchers (AB, AK, CB, CH, and JJ) in order to identify any studies which potentially met the study inclusion criteria. Full texts of any potentially relevant papers were then screened in full by two researchers independently to assess suitability. These were then discussed in pairs, and any disagreements were resolved through discussion and/or screening by a third researcher.
Authors were contacted for further information where results did not specify the effect of anxiety as an independent factor on the use of urgent healthcare, where healthcare was not specified as urgent or non-urgent, and where data on urgent healthcare use were not presented separately. Fifteen authors were contacted and nine responded within the pre-determined time frame of two weeks. Of the nine authors who responded, six were able to provide us with the requested data (see Appendix A for full information on studies included and excluded after author contact). Fig. 1 displays a summary of the study selection process.
Fig. 1.
PRISMA flow diagram.
Data extraction
Standardised data extraction sheets developed by study team members and piloted on previous occasions were used to extract data from studies included in the review. Data was extracted from the studies regarding participant characteristics, measure of anxiety used, measure of urgent care use, and the strength of association between anxiety and urgent care (both univariable and multivariable associations were extracted where possible).
Primary data extraction was performed on each included paper individually by two of five researchers (AB, AK, CB, CH, JJ), and compared between two members to ensure consistency in extracted data. Any disagreements were resolved through discussion.
Risk of bias in individual studies
The Quality Assessment Tool for Quantitative Studies was used in order to assess the methodological quality of individual studies [35], [36], dependent on whether there was:
-
a)
An absence of selection bias for participants
-
b)
Appropriate study design
-
c)
Adequate control for confounding factors
-
d)
Participants blinding to research question
-
e)
Assessors blinding to participant's anxiety status
-
f)
Valid and reliable data collection methods
-
g)
Appropriate action taken for participant withdrawal
-
h)
Appropriate use of analytical methods (The item of quality assessment relating to the integrity of interventions was excluded from the assessment).
Two researchers independently assessed the quality of studies; with consensus being reached through discussion when any disagreements occurred (the full quality assessment can be found in Table 3).
Table 3.
Quality assessment.
| Author & date | Selection bias | Design | Confounding | Blinding | Data collection | Drop outs | Global rating | Discrepancy between reviewers | Reasons for discrepancy | Final rating |
|---|---|---|---|---|---|---|---|---|---|---|
| [46] | 1 | 2 | 1 | 2 | 1 | 1 | 1 | N | 1 | |
| [41] | 3 | 2 | 2 | 2 | 1 | 2 | 2 | N | 2 | |
| [42] | 2 | 2 | 3 | 2 | 1 | 1 | 2 | Y | Blinding procedure | 2 |
| [43] | 3 | 2 | 1 | 2 | 3 | 2 | 3 | N | 3 | |
| [44] | 1 | 2 | 3 | 2 | 2 | 1 | 2 | N | 2 | |
| [45] | 3 | 2 | 1 | 2 | 1 | 1 | 2 | N | 2 | |
| [19] | 3 | 2 | 1 | 2 | 1 | 3 | 3 | N | 3 | |
| [20] | 2 | 2 | 2 | 2 | 1 | 2 | 1 | N | 1 |
Statistical analysis
Odds ratios (OR) and 95% confidence intervals (95% CIs) were extracted or calculated for each study where the number of participants using urgent care with and without anxiety was presented alongside the total number of subjects within each group. ORs > 1 indicated that anxiety was associated with an increased use of unscheduled care.
Where study data was presented in alternative formats (e.g. continuous data, p-value comparisons with group sizes, or as correlations), appropriate transformations were conducted using Comprehensive Meta Analysis software.
For data collected at multiple follow-up time points, ORs were calculated for the time point closest to 1 year in order to maximise consistency across studies. Where studies included more than one measure of urgent healthcare, ORs for each measure were averaged, ensuring that each study contributed only one effect measure to the meta-analysis [37]. ORs for anxiety were combined across the studies included using the DerSimonian and Laird random effects method [38], with heterogeneity among studies assessed using the Cochrane Q and I2 statistic [39], [40]. The I2 statistic is a measure of the percentage of variability in the effect estimate that is due to heterogeneity rather than due to chance. The suggested thresholds for the interpretation of I2 are < 25% suggesting low heterogeneity, < 50% which suggests moderate heterogeneity, and > 75% which suggests high heterogeneity [39].
Effects for anxiety are presented in both text and forest plot format.
Meta-analyses were performed using Comprehensive Meta-analysis (version 2.2.048, November 7th 2008). See Appendix A for the meta-analysis formulae used.
Results
Eight independent studies were identified which met the criteria for inclusion [19], [20], [41], [42], [43], [44], [45], [46], providing data from a total of 28,823 participants (range n = 37 to 26,591). The eight studies were conducted in various countries; two in the United Kingdom; one in the United States of America, China, Netherlands, Germany and Canada; and one study including five Nordic countries (Finland, Norway, Iceland, Sweden and Denmark). The studies detailed patients diagnosed with COPD [19], [20], [45], [46], asthma [41], [42], [44], and CHD [43]. See Table 1 for full characteristics of the studies included.
Table 1.
One study characteristics.
| 1st author and date | Condition of study | Sample size | Mean age (years) | % Males | Sample characteristics | Anxiety measure | Urgent healthcare utilisation/cost measure |
|---|---|---|---|---|---|---|---|
| [46] | COPD | 26,591 | 69.1 (SD 11.1) | 97% | Veterans with principal diagnosis of COPD exacerbation, acute or chronic bronchitis, chronic obstruction of the airway not elsewhere classified or acute and chronic respiratory failure. Excluded repeat admissions, cases with no ICD code of acute exacerbation of COPD (primary or secondary); no outpatient encounters in a year prior to admission; veterans admitted to facility with no acute care status or not initially admitted to an acute medical ward. | ICD-9 | Veteran Association 30 day re-admission records |
| [41] | Asthma | 256 | 56.3 (SD 16.4) | 38.3% | Previously performed spirometry or broncho-provocation. Attacks of dyspnoea and wheezing or with a known allergy. Heavy smokers likely to have COPD were to be avoided. | Validated German PHQ | Patient self-reported use |
| [42] | Asthma | 74 | 40.6 | 27% | Asthma attacks during the 20 months from October 1997. Control was selected from practice lists of patients identified as ever having asthma, only patients considered to have active asthma with duration of at least 3 years were included. The other group were patients with stable asthma matched to the other group in age, sex and BTS treatment. For more severe asthmatics, controls had to have not had an attack for a year. | 7 item panic fear scale of asthma symptom checklist, practice records & ACCS | Practice records A&E attendance and hospital attendance |
| [43] | CHD | 913 | 61.89 (SD 12) | 64.8% | Consecutive patients who were diagnosed with MI or UA in 12 CCUs across South-central Ontario, Canada. Diagnosed with a confirmed MI or unstable angina (UA) and were 18 years of age or older. Patients who were medically unstable or unable to read or speak English were excluded. | MHQ and Anxiety Subscale of the PRIME-MD | Patient self-reports on use |
| [44] | Asthma | 40 | 37.2 (SD 14) | 37.5% | Diagnosis of asthma, Netherlands natives between the ages of 16 and 60 years. | ASC-PF, STAI-DY, 20 PF, and NPV | Not stated |
| [45] | COPD | 491 | Not stated | < 66% | 30 years >; physician-diagnosed COPD; post bronchodilator FEV1/FVC ratio of less than 0.7 and FEV1 of less than 80% of predicted value; no fever, no worsening of respiratory symptoms, and no medication change within 4 weeks before recruitment; no primary diagnosis of asthma; no previous lung volume reduction surgery, lung transplantation, or pneumonectomy; and expected survival > 6 months. | Mandarin HADS | Patient self reports on use |
| [19] | COPD | 416 | 69.2 (SD 10.5) | 48.8% | Admitted for > 24 h with acute exacerbations of obstructive lung disease (asthma, chronic bronchitis, chronic obstructive bronchitis or emphysema) during the year 2000–2001. Fulfilled criteria for COPD according to the Global initiative for chronic obstructive pulmonary disease (GOLD) stage I or higher. No diagnosis of asthma. | HADS | Patient self-report on use |
| [20] | COPD | 79 | 65.3 (SD 9.9) | 44% | Validated diagnosis of COPD, with post-bronchodilator FEV1 < 80% of predicted, FEV/FVC ratio < 70%. MMSE > 7, Systolic BP > 100 mm Hg, white cell count (× 109/1) 4–20, potassium between 3.5 and 5 mmol/l, arterial blood pH > 7.35, pO2 > 8 kPa, pCO2 < 6.7 kPa, registered with Manchester GP with adequate social support. Exclusions; suspected underlying malignancy, pneumothorax, uncontrolled atrial fibrillation, acute ECG changes, full time nursing, IV therapy, cardiac chest pain, insulin dependent diabetes, pneumonia/consolidation, chest X-ray changes, pulmonary embolism, history of falls, severe and enduring mental health problems, not English speaker. | HADS | Medical records |
Anxiety was assessed using self-report questionnaires in seven out of eight studies [19], [20], [41], [42], [43], [44], [45], with one study using the ICD-9 diagnostic codes taken from patients' notes [46]. There were no cases when more than one measure of anxiety was presented. Four studies assessed the use of urgent care using self-report questionnaires [19], [41], [43], [45], and six studies used hospital admission and medical records [19], [20], [42], [43], [44], [46].
Of the eight studies included in the review, none showed significant effects of anxiety on the use of urgent healthcare, with only one paper showing near significant effects [41]. The independent study effects are presented in the forest plot (Fig. 2). The combined effect (OR) for anxiety across all studies included in the analysis was OR = 1.078 (95% CI 0.877–1.325), p = 0.476. Effects of individual studies showed a relatively low level of heterogeneity (Q = 9.5, d.f. = 7, p = 0.221, I2 = 26.07%), which is supported by the insignificance of Q. [46] included a much larger sample size than the remaining seven papers in the review, with a total of 26,591 patients, of whom 97% were male. Further sensitivity analysis was conducted in order to assess whether this study affected the meta-analysis outcome. The combined effect (OR) for anxiety across these studies was OR = 1.238 (95% CI 0.969–1.551), p = 0.087 (see Appendix A). Effects of these studies showed a very low level of heterogeneity (Q = 5.116, d.f. = 5, p = 0.402, I2 = 2.27%), which is again supported by the insignificance of Q.
Fig. 2.
Forest plot anxiety and unscheduled care.
Effects of anxiety did vary across the different types of urgent care used between studies although none of the effects were significant: ED visits [n = 1, OR = 1.360 (95% CI 0.889, 2.081), p = 0.156], hospitalisation [n = 5, OR = 1.002 (95% CI 0.876, 1.146), p = 0.976], GP visits, ED or hospitalisation [n = 1, OR = 0.616 (95% CI 0.250, 1.516), p = 0.291], and combined hospitalisation and GP visits [n = 1, OR = 4.099 (95% CI 0.935, 17.965), p = 0.061]. Comparison across groups using the analog of ANOVA revealed that these differences in effect size across various types of urgent care were not statistically significant (Q = 6.4, d.f. = 3, p = 0.093).
The effect of anxiety also varied across the different LTMCs included in the review; however none of the effects were significant: asthma [n = 3, OR = 1.355 (95% CI 0.462, 3.976), p = 0.580]; CHD [n = 1, OR = 1.360 (95% CI 0.889, 2.081), p = 0.156]; COPD [n = 4, OR = 0.998 (95% CI 0.872, 1.143) p = 0.978]. Comparison across groups revealed that these differences in effect size across the different LTCs were not statistically significant (Q = 2.1, d.f. = 2, p = 0.350).
The pooled meta-analysis was repeated for the studies grouped according to their methodological quality rating. This revealed the following effect sizes: methodologically strong studies: n = 2, OR = 0.927 (95% CI 0.701, 1.226), p = 0.594; methodologically moderate studies: n = 4, OR = 1.243 (95% CI 0.650, 2.375), p = 0.511; methodologically weak studies: n = 2, OR = 1.258 (95% CI 0.955, 1.656), p = 0.102. Comparing effects across studies grouped by methodological quality using the analog of ANOVA revealed no significant difference in the effect sizes (Q = 2.5, d.f. = 2, p = 0.288).
Multivariable analysis
Of the 8 studies included, only 4 reported conducting multivariable analysis that controlled for severity of the LTC among other covariates {Grace et al. [43]; Abrams et al. [46]; Gudmundsson et al. [19]; Coventry et al. [20]}. These 4 studies used various measures of severity of LTC including cardiac event occurrence, length of exacerbation, St. George's Respiratory Questionnaire (SGRQ) and 30 day readmission.
Based on the reported results of multivariable analysis, where illness severity was controlled for, anxiety did contribute significantly to the multivariable models in two of the four studies. Grace et al. [43] found that depression; older age and a history of cardiovascular disease were significant predictors of self-reported recurrent cardiac events, whereas anxiety led to significantly less self-reported cardiac events (OR = 0.35, 95% CI = 0.19–0.65, p = < 0.01). Gudmundsson et al. [19] found anxiety was significantly associated with increased risk of urgent hospitalisation in a subgroup of patients who had poor health related quality of life, when analysed using Cox regression, Hazard ratio (HR) = 1.73 (95% CI, 1.18–2.53). Coventry et al. [20] found that the only significant predictors of readmission within 365 days of discharge were depression, odds ratio (OR) = 1.300 (95% CI, 1.06–1.60), p = 0.013, FEV, OR = 0.962 (95% CI, 0.93–0.99), p = 0.021, and age, OR = 1.092 (95% CI, 1.01–1.18), p = 0.026. Abrams et al. [46] found that controlling for smoking status made no changes to the effect of anxiety on risk of admission (smoking present HR = 1.22 (95% CI 1.04–1.44), smoking absent HR = 1.22 (95% CI 1.03–1.43)). See Table 2 for a full description of results.
Table 2.
Main findings of studies included in review.
| Author & date | Univariable findings | Factors controlled | Multivariable findings |
|---|---|---|---|
| [46] | Patients with anxiety were not more significantly likely to be readmitted than those without anxiety (11.3% vs. 11.5% [NS]). | Smoking status. | No significant difference in risk of admission regardless of smoking status. Smoking present HR = 1.22, 95% CI 1.04–1.44, smoking absent HR = 1.22, 95% CI 1.03–1.43. |
| [41] | Panic disorder did not predict hospitalisation (OR = 3.5, 95% CI = 0.7–18.3, p = 0.145), but did predict emergency visits (OR = 4.8, 95% CI 1.3–17.7, p = 0.019). | ||
| [42] | There was no main effect of panic (p > 0.05). | ||
| [43] | Anxious patients (1.11 [1.57]) reported more visits to the emergency department than non anxious (0.83 [1.18]) patients (t = − 1.37, p = 0.17). However, this was NS. | Age, family history of CVD, depression, Killip class, sex, family income, smoking status, diabetes and phobic anxiety. | Age (OR = 1.02, 95% CI 1.00–1.05, p = 0.05), family history of CVD (OR = 1.63, 95% CI 1.04–2.54, p = 0.03), depression (OR = 1.07, 95% CI 1.03–1.12, p = < 0.01) and prime-MD anxiety at 6 months (OR = 0.35, 95% CI = 0.19–0.65, p = < 0.01), were all significant predictors of self-reported recurrent cardiac events. All other factors NS. |
| [44] | State and trait anxiety not associated with increased length of hospitalisations. State anxiety not significantly associated with readmission, however trait anxiety had slight effect (1-tailed t = 1.72, p = 0.048). |
||
| [45] | Anxiety not associated with increased risk of urgent hospital admission (p = 0.11), however length of exacerbation in days was longer for patients with anxiety than for those without (p = 0.03). | Age, sex, smoking, marital status, education, employment, living situation, FEV1, dyspnoea score, six-minute-walk distance, social support, chronic obstructive pulmonary disease-specific self-efficacy, significant comorbidities, hospital type, use of long-acting bronchodilator and inhaled corticosteroid, long-term oxygen therapy and past hospitalisation. | Anxiety was not associated with hospitalisation: Incidence Rate Ratio = 1.63 (0.88 to 3.03) for HADS anxiety ≥ 11, or for lengthy of hospitalisation for those readmitted: IRR = 1.99 (0.59 to 6.72). |
| [19] | Anxiety had no significant effect on rehospitalisation (p = 0.61). No significant difference between HADS anxiety scores for those who were readmitted (7.1 [4.3]) and those who were not (6.7 [4.0], p = 0.28) | Age smoking status, FEV, SGRQ. | Significant association between the HAD anxiety score and the risk of re-admission in patients with a low health status (HR = 0.81 95% CI = 0.63–1.04). In the same group, anxiety (HADS score ≥ 8) was related to increased risk of rehospitalisation (HR = 0.43 95% CI = 0.25–0.74). |
| [20] | No significant difference between HADS anxiety scores for those who were readmitted (8.53 ± 4.2) and those who were not (9.47 ± 4.6, p = 0.407) | Age, race, gender, individual medical comorbidities and laboratory values. | Depression (OR = 1.300, (95% CI, 1.06–1.60), p = 0.013), FEV score (OR = 0.962, (95% CI, 0.93–0.99), p = 0.021), and age (OR = 1.092, (95% CI, 1.01–1.18), p = 0.026) were the only significant predictors of readmission. Anxiety was insignificant. |
Risk of bias within individual studies
Details of the quality of studies included within the analysis are presented in Table 3. Two studies were rated as strong (no weak ratings) [20], [46], four were rated as moderate (one weak rating) [41], [42], [44], [45] and two were rated as weak (more than one weak rating) [19], [43].
Publication bias
The contour enhanced funnel plot did not appear to be asymmetrical, except for one small negative study (Fig. 3), and Egger's regression method confirmed the lack of association between logeOR and standard error of logeOR. Egger's bias = 1.24, 95% CI − 1.01 to 3.48, p = 0.23.
Fig. 3.
Contour enhanced funnel plot: logeOR vs standard error of logeOR.
The Duval and Tweedie trim and fill procedure created just 1 imputed study, giving a revised random effects combined odds ratio for anxiety across all studies of 1.05 (95% CI 0.82 to 1.33), p = 0.69 (see Appendix A). This is only very slightly reduced compared with the original, and still not significant. The heterogeneity between studies is increased slightly, and still significant (Q = 12.9, df = 8, p = .040).
Discussion
A systematic review with meta-analysis was conducted to determine whether anxiety is associated with the use of urgent care in patients with LTCs. On combining univariate findings from 8 independent studies, anxiety was not significantly associated with increased use of urgent healthcare. Effects for anxiety were also not statistically significant across different types of urgent healthcare use or different LTCs. Our findings were not significantly influenced by studies with low methodological quality. Three out of the four studies presenting multivariable analyses suggested anxiety had some effect on either urgent healthcare use, exacerbation in days, or recurrent illness, independent of severity of anxiety. However, these three studies which reported positive associations had relatively poorer methodological quality than the study which reported no such findings [20].
Our review has several strengths. First we conducted extensive searching of key electronic databases and sought expert advice from professionals within the area on potentially relevant studies. This enabled us to identify as many relevant studies as possible. Furthermore, to increase the identification of relevant papers, we chose not to limit search terms to urgent healthcare, instead we kept search terms broad, searching all healthcare use first and then hand-searching the results to find papers relevant to urgent care. Our methodological quality was further enhanced by inclusion of all relevant papers, regardless of year of publication, language of publication, sample size, or duration of follow-up. Data extraction was conducted by independent researchers with findings compared between researchers, to ensure reliability of results. We believe that our methodological rigour in identifying relevant papers contributed to the homogeneity of our findings within the analysis.
Our review has several limitations. Firstly, our decision to limit the review to four exemplar LTCs means that our findings may not be generalisable to all LTC populations. However, COPD, CHD, asthma and diabetes are all common conditions [33] with relatively high levels of psychological morbidity [47]. Three of the four LTCs are considered to be among the most burdensome non-communicable diseases worldwide [33] and are among the leading patient discharge diagnoses from emergency departments [48].
A second limitation is that we rated studies using a quality scoring system, which categorised studies according to the number of ‘weak’ characteristics displayed within the paper. The main advantage of doing this is that it allowed us to conduct sensitivity analyses to investigate the impact of quality on the observed effects of anxiety on urgent healthcare use. We recognise that in presenting quality extraction data in this way, it could be argued that we assumed all methodological weaknesses to carry an equal weight, so we have also included within the paper a table displaying how each study was scored, to enable readers to interpret quality themselves. Finally, the number of relevant papers included in this paper was quite small, with the result that our meta-analysis lacked statistical power. However, we do not think that a lack of power has affected the main result; OR for anxiety on urgent healthcare = 1.08 is very small and of little if any clinical significance irrespective of the statistical significance. Some of the subgroup analyses, for example, those demonstrating differences in effect across type of urgent care or type of long term condition, were quite large in magnitude (differences in odds ratios up to 70%) but failed to reach statistical significance, which may, at least in part, be due to a lack of statistical power.
Our original hypothesis was informed by literature which did not meet the criteria for inclusion in this review but suggested that anxiety significantly increased the healthcare use of some patients with our four specified LTCs [49], [50], [51], [52], as well as in other LTCs such as irritable bowel syndrome (IBS) [53] and sickle cell disease [54]. Whilst differences between different LTCs may be expected, the findings suggestive of a link between anxiety and urgent care in our 4 exemplar conditions, primarily arise from studies that have employed a cross sectional design. Our findings from this systematic review, suggest that the relationship between anxiety and use of urgent care becomes much weaker, if patients are studied prospectively. This is supported by findings from prospective cohort studies which have investigated other LTCs [55], [56] which suggest anxiety does not play a role in influencing urgent healthcare use.
Anxiety is clearly associated with a variety of poor outcomes in people with LTCs [31], [32], [65], [66]. A possible explanation for the ‘lack of effect’ of anxiety on urgent care may be that it is difficult to disentangle the impact of anxiety on healthcare use from the effects of co-morbid depressive symptoms. In a previous systematic review and meta-analysis depression was shown to be associated with an increased risk of up to 50% in the use of urgent care in patients with LTCs [23]. Depression and anxiety are highly correlated [57], [58] and often co-occur [59]. However, our findings suggest that there may be characteristics specific to depression that lead to a greater use of urgent care; characteristics which are not found in anxiety. It is possible that depression results in greater self neglect [60], [61] and less adherence with routine treatment [62], [63], which then leads on to more acute illness exacerbations and greater need for urgent care. Depression is also associated with negative self efficacy, which may make it particularly difficult for people to cope at times of ‘health crises’ [64].
Anxiety may only present a significant effect on use of urgent care within people with LTCs when associated with other psychological factors such as health related quality of life [67], [68]. Or it may be that certain anxiety disorders, such as panic disorder, have a greater impact on use of urgent care than generalised anxiety [69]. It was not possible to address these questions within the scope of this review due to the relatively small number of studies we identified. However, as the literature develops in this area, future reviews could use techniques such as meta-regression to tease out the impact of a wider range of more specific psychological variables on use of urgent care.
Although our findings suggest anxiety is not associated with use of urgent care, it is associated with many other adverse outcomes. There remains a requirement to identify and treat anxiety in people with LTCs.
Acknowledgements
Author's contributions
Blakeley conducted searches, screened titles and abstract to identify eligible papers, assisted in data extraction, constructing draft papers, conducted meta-analysis, contributed to the paper and approved the final draft.
Blakemore conducted searches, screened titles and abstract to identify eligible papers, assisted in data extraction, constructed and reviewed draft papers, conducted meta-analysis, contributed to the paper and approved the final draft.
Dickens assisted in the design of the study, supervised meta-analysis and reviewed draft papers, contributed to the paper and approved the final draft.
Guthrie assisted in design of study, supervised meta-analysis, constructed and reviewed draft papers, contributed to the paper and approved the final draft.
Hunter conducted search, screened titles and abstract to identify eligible papers, assisted in data extraction, constructed and reviewed draft papers, and approved the final draft.
Tomenson conducted meta-analysis, produced funnel plots and conducted Duvall & Tweedie trim and fill procedure, reviewed draft papers and approved the final draft.
Other acknowledgements
Judy Jackson assisted in initial searched and screening of titles and abstracts to identify eligible papers, and also data extraction.
Angee Khara assisted in searches and screening of titles and abstracts to identify eligible papers, and also data extraction.
Rosalind McNally, librarian, advised on the electronic search strategies.
Information on access to data
The authors are independent of any commercial funder or sponsor and have had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Disclosure of potential conflicts of interest, activities, relationships and affiliations
None of the authors have conflicts of interests or financial interests to declare.
Sources of funding and support
This study was funded by a programme grant from the National Institute of Health Research (NIHR), UK.
Role of the sponsor
The sponsor has provided funding for this project but played no part in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Disclaimer
This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10162). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Information on previous presentations
The findings contained in this document have not previously been presented or published.
Listing of supplemental material
Additional material is included in the material for online only appendix, including full PICO criteria, details of search strategies used and databases searched, the formula used in the meta-analysis, figure displaying results of Duvall and Tweedie's trim and fill, and a list of references for papers included in this review.
Contributions of others compensated for their contributions
No individuals were compensated for their contribution to this article.
Footnotes
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jpsychores.2014.06.010.
Appendix A. Supplementary data
Supplementary material.
References
- 1.Singh D. WHO Regional Office for Europe and European Observatory on Health Systems and Policies; Tallin, Estonia: June 25–27th 2008. How can chronic disease management programmes operate across care settings and providers? (WHO ministerial conference on health systems). [Google Scholar]
- 2.Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the US healthcare workforce do the job? Health Aff. 2009;28:64–74. doi: 10.1377/hlthaff.28.1.64. [DOI] [PubMed] [Google Scholar]
- 3.Technology Strategy Board . 2009. Managing long-term conditions — remote monitoring. Completion for development contracts. [Google Scholar]
- 4.Wilson T, Buck D, Ham C. Rising to the challenge: will the NHS support people with long term conditions? Br Med J. 2005;330:657–661. doi: 10.1136/bmj.330.7492.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Magid DJ, Houry D, Ellis J, Lyons E, Rumsfeld JS. Health-related quality of life predicts emergency department utilisation for patients with asthma. Ann Emerg Med. 2004;43:551–557. doi: 10.1016/j.annemergmed.2003.11.021. [DOI] [PubMed] [Google Scholar]
- 6.Tsai CL, Griswold SK, Clark S, Camargo CA. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Int Med. 2007;22:799–804. doi: 10.1007/s11606-007-0191-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Department of Health . 2012. (Annual report of accounts 2011–2012). [Google Scholar]
- 8.Thompson C, Hayhurst C, Boyle A. How have changes to out of hours primary care services since 2004 affected emergency department attendances at a UK District General Hospital? A longitudinal study. Emerg Med J. 2010;27:22–25. doi: 10.1136/emj.2008.068817. [DOI] [PubMed] [Google Scholar]
- 9.Lowthian JA, Curtis AJ, Jolley D, Stoelwinder JU, McNeil JJ, Cameron PA. Demand at the emergency department front door: 10 year trends in presentations. Med J Aust. 2012;196:128–132. doi: 10.5694/mja11.10955. [DOI] [PubMed] [Google Scholar]
- 10.Goodwin RD, Pagura J, Cox B, Sareen J. Asthma and mental disorders in Canada: impact on functional impairment and mental health service use. J Psychometric Res. 2010;68:165–173. doi: 10.1016/j.jpsychores.2009.06.005. [DOI] [PubMed] [Google Scholar]
- 11.Hughes AK, Woodward AT, Velez-Ortiz D. Chronic illness intrusion: role impairment and time out of role in racially and ethnically diverse older adults. Gerontologist. 2013;41:1. doi: 10.1093/geront/gnt041. [DOI] [PubMed] [Google Scholar]
- 12.Hert MD, Correll CV, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I. Physical illness in patients with severe mental disorders. I. Prevalence impact of medications and disparities in health care. World Psychiatry. 2013;10:52–77. doi: 10.1002/j.2051-5545.2011.tb00014.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Gunn JM, Ayton DR, Densley K, Pallant JF, Chondros P, Herrman HE, Dowrick CF. The association between chronic illness, multi-morbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol. 2012;47:175–184. doi: 10.1007/s00127-010-0330-z. [DOI] [PubMed] [Google Scholar]
- 14.Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry. 2011;199:441–442. doi: 10.1192/bjp.bp.111.092718. [DOI] [PubMed] [Google Scholar]
- 15.Van Melle JP, De Jonge P, Spukerman TA, Tussen JGP, Ormel J, Van Veldhuisen DJ. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814–822. doi: 10.1097/01.psy.0000146294.82810.9c. [DOI] [PubMed] [Google Scholar]
- 16.Strine TW, Chapman DP, Balluz LS, Moriatry DG, Mokdad AH. The associations between life satisfaction and health-related quality of life, chronic illness and health behaviours among US community-dwelling adults. J Community Health. 2008;33:40–50. doi: 10.1007/s10900-007-9066-4. [DOI] [PubMed] [Google Scholar]
- 17.Omachi TA, Katz PP, Yelin EH, Gregorich SF, Iribarren C, Blanc PD, Eisner MD. Depression and health related quality of life in chronic obstructive pulmonary disorder. Am J Med. 2009;1:36. doi: 10.1016/j.amjmed.2009.01.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Reese RL, Freedland KE, Steinmeyer BC, Rich MW, Rackley JW, Carney RM. Depression and re-hospitalisation following acute myocardial infarction. Circulation. 2011;4:626–633. doi: 10.1161/CIRCOUTCOMES.111.961896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS. Risk factors for re-hospitalisation in chronic obstructive pulmonary disorder: role of health status, anxiety and depression. Eur Respir J. 2005;26:41. doi: 10.1183/09031936.05.00078504. [DOI] [PubMed] [Google Scholar]
- 20.Coventry PA, Gemmell I, Todd CJ. Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med. 2011;11:49. doi: 10.1186/1471-2466-11-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Yoon J, Yano EM, Altman L, Cordasco KM, Stockdale SE, Chow A. Reducing costs of acute care for ambulatory care sensitive medical conditions: the central role of co-morbid mental illness. Med Care. 2012;50:705–713. doi: 10.1097/MLR.0b013e31824e3379. [DOI] [PubMed] [Google Scholar]
- 22.Katon WJ, Young BA, Russo J, Lin EH, Ciechanowski P, Ludman EJ, Von Korff MR. Association of depression with increased risk of severe hypoglycaemic episodes in patients with diabetes. Ann Fam Med. 2013;11:245–250. doi: 10.1370/afm.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dickens C, Katon W, Blakemore A, Khara A, McGowan L, Tomenson B, Jackson J, Walker L, Guthrie E. Does depression predict the use of urgent and unscheduled care by people with long term conditions? A systematic review with meta-analysis. J Psychosom Res. 2012;73:334–342. doi: 10.1016/j.jpsychores.2012.08.018. [DOI] [PubMed] [Google Scholar]
- 24.Anesetti-Rothermel A, Sambamoorthi V. Physical and mental illness burden: disability days among working age adults. Popul Health Manag. 2011;14:223–230. doi: 10.1089/pop.2010.0049. [DOI] [PubMed] [Google Scholar]
- 25.Hakola R, Kauppi P, Leino T, Ojajarvi A, Pentti J, Oksanen T. Persistent asthma, co-morbid conditions and the risk of work disability: a prospective cohort study. Eur J Allergy Clin Immunol. 2011;66:1598–1603. doi: 10.1111/j.1398-9995.2011.02729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.McIntyre RS, Liauw S, Taylor VH. Depression in the workforce: the intermediary effect of medical co-morbidity. J Affect Disord. 2011;128:529–536. doi: 10.1016/S0165-0327(11)70006-4. [DOI] [PubMed] [Google Scholar]
- 27.Kessler RC. In: A handbook for the study of mental health, social contexts theories systems. Scheid TL, Brown TN, editors. Cambridge University Press; 2010. The prevalence of mental illness. [Google Scholar]
- 28.McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, co-morbidity and burden of illness. J Psychiatr Res. 2011;45:1027–1035. doi: 10.1016/j.jpsychires.2011.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fleet R, Lavoie K, Bietman BD. Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res. 2000;48:347–356. doi: 10.1016/s0022-3999(99)00101-4. [DOI] [PubMed] [Google Scholar]
- 30.Australian Cancer Network . Cancer Council of Australia; 2004. Clinical practice guidelines for the prevention, diagnosis and management of lung cancer. [Google Scholar]
- 31.Kessler RC, Ormel J, Dmeler O, Stang PE. Co-morbid mental disorders account for the role impairment of commonly occurring chronic phycial disorders: results from the National Co-morbidity Survey. J Occup Environ Med. 2003;45:1257–1266. doi: 10.1097/01.jom.0000100000.70011.bb. [DOI] [PubMed] [Google Scholar]
- 32.De Godoy DV, De Godoy RF. Randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disorder. Arch Phys Med Rehabil. 2003;84:1154–1157. doi: 10.1016/s0003-9993(03)00239-9. [DOI] [PubMed] [Google Scholar]
- 33.World Health Organisation Global status report on noncommunicable diseases 2010 description of the global burden of NCDs, their risk factors and determinants. 2011;1:9. [Google Scholar]
- 34.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009:339. [PMC free article] [PubMed] [Google Scholar]
- 35.Effective public health practice project . 2009. Qualitative assessment tool for quantitative studies dictionary. [Google Scholar]
- 36.Effective public health practice project . 2011. Quality assessment tool for quantitative studies. [Google Scholar]
- 37.Lipsey M, Wilson D. Sage Publications; London: 2001. Practical meta-analysis. [Google Scholar]
- 38.Egger M, Davey SG, Altman DG. BMJ Publishing; London: 2001. Systematic reviews in health care: meta-analysis in context. [Google Scholar]
- 39.Higgins JP, Thomson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Moreno S, Sutton A, Ades A, Stanley T, Abrams K, Peters J. Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med Res Methodol. 2009:9. doi: 10.1186/1471-2288-9-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schneider A, Lowe B, Meyer FJ, Biessecker K, Joos S, Szecsenyi J. Depression and panic disorder as predictors of health outcomes for patients with asthma in primary care. Respir Med. 2008;102:359–366. doi: 10.1016/j.rmed.2007.10.016. [DOI] [PubMed] [Google Scholar]
- 42.Greaves CJ, Eiser C, Seamark D, Halpin DMG. Attack context: an important mediator of the relationship between psychological status and asthma outcomes. Thorax. 2002;57:217. doi: 10.1136/thorax.57.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Grace SL, Abbey SE, Irvine J, Schnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom. 2004;73:344–352. doi: 10.1159/000080387. [DOI] [PubMed] [Google Scholar]
- 44.Kaptein AA. Psychological correlates of length of hospitalisation and rehospitalisation in patients with acute, severe asthma. Soc Sci Med. 1982;16:725–729. doi: 10.1016/0277-9536(82)90463-4. [DOI] [PubMed] [Google Scholar]
- 45.Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalisations. Am J Respir Crit Care Med. 2008:178. doi: 10.1164/rccm.200804-619OC. [DOI] [PubMed] [Google Scholar]
- 46.Abrams TE, Vaughan-Sarrazin M, Vander Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52:441–449. doi: 10.1016/j.psym.2011.03.005. [DOI] [PubMed] [Google Scholar]
- 47.Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illnesses. Gen Hosp Psychiatry. 2007;29:147–155. doi: 10.1016/j.genhosppsych.2006.11.005. [DOI] [PubMed] [Google Scholar]
- 48.Niska R, Farida B, Jianmin X. National hospital ambulatory medical care survey: 2007 emergency department summary. Natl Health Stat Rep. 2010;26:1–31. [PubMed] [Google Scholar]
- 49.Fernandes L, Fonseca J, Martins S, Delgado L, Costa Pereira A, Vaz M, Branco G. Association of anxiety with asthma: subjective and objective outcome measures. Psychosomatics. 2010;51:39–46. doi: 10.1176/appi.psy.51.1.39. [DOI] [PubMed] [Google Scholar]
- 50.Di Marco F, Verga M, Santus P, Giovannelli F, Busatto P, Neri M, Girbino G, Bonini S, Centanni S. Close correlation between anxiety, depression, and asthma control. Respir Med. 2010;104:22–28. doi: 10.1016/j.rmed.2009.08.005. [DOI] [PubMed] [Google Scholar]
- 51.Kim H, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41:465–471. doi: 10.1176/appi.psy.41.6.465. [DOI] [PubMed] [Google Scholar]
- 52.Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J COPD. 2014;9:315–330. doi: 10.2147/COPD.S53255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Hu WHC, Wong W, Lam CLK, Lam KF, Hui WM, Lai KC, Xia HXH, Lam SK, Wong BCY. Anxiety but not depression determines health care seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population based study. Aliment Pharmacol Ther. 2002;2081–2088:16. doi: 10.1046/j.1365-2036.2002.01377.x. [DOI] [PubMed] [Google Scholar]
- 54.Aisiku IP, Smith WR, McClish DK, Levenson JL, Penberthy LT, Roseff SD, Bovbjerg VE, Roberts JD. Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med. 2009;53:587–593. doi: 10.1016/j.annemergmed.2008.07.050. [DOI] [PubMed] [Google Scholar]
- 55.Levenson JL, McClish DK, Dahman BA, Bovbjerg VE, Citero VD, Penberthy LT, Aisiku IP, Roberts JD, Roseff SD, Smith WR. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med. 2008;70:192–196. doi: 10.1097/PSY.0b013e31815ff5c5. [DOI] [PubMed] [Google Scholar]
- 56.Richardson LP, Russo JE, Lozano P, McCauley E, Katon W. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry. 2008;30:398–406. doi: 10.1016/j.genhosppsych.2008.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Light RW, Merrill E, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. CHEST J. 1985;87:35–38. doi: 10.1378/chest.87.1.35. [DOI] [PubMed] [Google Scholar]
- 58.Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, Nolen WA, Zitman FG, Beekman AT, Penninx BW. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA) J Clin Psychiatry. 2011;72:341–348. doi: 10.4088/JCP.10m06176blu. [DOI] [PubMed] [Google Scholar]
- 59.Schoevers RA, Beekman ATF, Deeg DJH, Jonker C, Tilburg WV. Comorbidity and risk patterns of depression, generalised anxiety disorder and mixed anxiety depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry. 2003;18:994–1001. doi: 10.1002/gps.1001. [DOI] [PubMed] [Google Scholar]
- 60.Egede LE, Osborn CY. Role of motivation in the relationship between depression, self-care, and glycemic control in adults with type 2 diabetes. Diabetes Educ. 2010;36:276–283. doi: 10.1177/0145721710361389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Egede LE, Ellis C, Grubaugh AL. The effect of depression on self-care behaviours and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry. 2009;31:422–427. doi: 10.1016/j.genhosppsych.2009.06.007. [DOI] [PubMed] [Google Scholar]
- 62.DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107. doi: 10.1001/archinte.160.14.2101. [DOI] [PubMed] [Google Scholar]
- 63.Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154–2160. doi: 10.2337/diacare.27.9.2154. [DOI] [PubMed] [Google Scholar]
- 64.Arnstein P, Caudill M, Mandle C L, Norris A, Beasley R. Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain. 1999;80:483–491. doi: 10.1016/S0304-3959(98)00220-6. [DOI] [PubMed] [Google Scholar]
- 65.Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30:208–225. doi: 10.1016/j.genhosppsych.2007.12.006. [DOI] [PubMed] [Google Scholar]
- 66.Feldman JM, Siddique MI, Morales E, Kaminski B, Lu SE, Lehrer PM. Psychiatric disorders and asthma outcomes among high-risk inner-city patients. Psychosom Med. 2005;67:989–996. doi: 10.1097/01.psy.0000188556.97979.13. [DOI] [PubMed] [Google Scholar]
- 67.Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Health related quality of life and healthcare utilisation in multimorbidity: results of a cross-sectional study. Qual Life Res. 2013;22:791–799. doi: 10.1007/s11136-012-0214-7. [DOI] [PubMed] [Google Scholar]
- 68.Levenson SA, McClish DK, Rosef SD, Smith WR. Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project. Psychosomatics. 2011;52:272–279. doi: 10.1016/j.psym.2011.01.010. [DOI] [PubMed] [Google Scholar]
- 69.Deacon B, Lickel J, Abramowitz JS. Medical utilization across the anxiety disorders. J Anxiety Disord. 2008;22:344–350. doi: 10.1016/j.janxdis.2007.03.004. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary material.



